The Negative Aspects of Granulocyte Transfusions

References

• McCullough J. Leukapheresis and granulocyte transfusion. Crit Rev Clin Lab Sci 1979; 10: 275–327
   Web of Science ®Google Scholar
• Morse E E, Freireich E J, Carbone P P, et al. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion 1966; 6: 183–192
   Web of Science ®Google Scholar
• Buckner D, Graw R G, Jr, Eisel R J, et al. Leukapheresis by continuous-flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood 1969; 22: 353–369
   Google Scholar
• Goldstein I M, Eyre H G, Terasaki P I, et al. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion 1971; 11: 19–24
   PubMed Web of Science ®Google Scholar
• Schiffer C A, Buchholz D H, Aisner J, et al. Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukapheresis. Am J Med 1975; 58: 373–381
   PubMed Web of Science ®Google Scholar
• Ungerleider R S, Appelbaum F R, Trepani R J, Deisseroth A B. Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy. Transfusion 1979; 19: 90–94
   PubMed Web of Science ®Google Scholar
• Goldman J M, Heim L, Wright D G. Filtration leukapheresis: review and re-evaluation. Exp Hematol 1979; 7: 1–51
   Web of Science ®Google Scholar
• Hammerschmidt D E, Craddock P R, McCullough J, et al. Complement activation and pulmonary dysfunction during nylonfiber filtration leukapheresis. Blood 1978; 51: 721–730
   PubMed Web of Science ®Google Scholar
• Dale D C, Reynolds H Y, Pennington J E, et al. Granulocyte transfusion therapy of experimental pseudomonas pneumonia. J Clin Invest 1974; 54: 664–671
   PubMed Web of Science ®Google Scholar
• Winston D J, Ho W G, Howell C L, et al. Cytomegalovirus infections associated with leukocyte transfusion. Ann Intern Med 1980; 93: 671–675
   PubMed Web of Science ®Google Scholar
• Strauss R G, Connett J E, Gale R P, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 1981; 305: 597–603
   PubMed Web of Science ®Google Scholar
• Hersman J H, Meyers J D, Thomas E D, et al. The effect of granulocyte transfusions on the incidence of Cytomegalovirus infection after allogeneic bone marrow transplantation. Ann Intern Med 1982; 96: 142–152
   Google Scholar
• Wright D G, Robichaud K J, Pizzo P A, Deisseroth A B. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304: 1185–1189
   PubMed Web of Science ®Google Scholar
• Dana B W, Durie B GM, White R F, Heustis D W. Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood 1981; 57: 90–94
   PubMed Web of Science ®Google Scholar
• Forman S J, Robinson G V, Wolf J L, et al. Pulmonary reactions associated with amphotericin B and leukocyte transfusions (letter). N Engl J Med 1981; 305: 584–585
   PubMed Web of Science ®Google Scholar
• DeGregorio M W, Lee W MF, Ries C A. Pulmonary reactions associated with amphotericin B and leukocyte transfusions (letter). N Engl J Med 1981; 305: 585
   Web of Science ®Google Scholar
• Karp D D, Ervin T J, Tuttle S, et al. Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang 1982; 47: 57–61
   Google Scholar
• Dana B W, Durie B GM, White R F, Heustis D W. The significance of pulmonary infiltrates developing in patients receiving granulocyte transfusions. Br J Haematol 1983; 53: 437–443
   PubMed Web of Science ®Google Scholar
• Bow E J, Schroeder M L, Louie T J. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J 1984; 130: 593–597
   PubMed Web of Science ®Google Scholar
• Clift R A, Buckner C D. Granulocyte transfusions. Am J Med 1984; 76: 631–636
   PubMed Web of Science ®Google Scholar
• Boxer L A, Ingraham L M, Allen J, et al. Amphotericin B promotes leukocyte aggregation of nylon-wool-fiber-treated polymorphonuclear leukocytes. Blood 1981; 58: 518–523
   PubMed Web of Science ®Google Scholar
• Herzig G P, Bull M I, Lohrmann H-P, . Impaired transfusion response to granulocytes collected by filtration leukapheresis. Leukocytes: Separation, Collection, and Transfusion, J M Goldman, R M Lowenthal, et al. Academic Press, London 1975; 324–328
   Google Scholar
• Strauss R G, Spitzer R E, Stitzel A E, et al. Complement change during leukapheresis. Transfusion 1980; 20: 32–38
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D E, Weaver L J, Hudson L D, et al. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome. Lancet 1980; 2: 947–949
   Google Scholar
• Siegel S E, Lunde M N, Gelderman A H, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971; 37: 388–394
   PubMed Web of Science ®Google Scholar
• Levin R H, Whang J, Tiji J H, et al. Persistent mitosis of homologous leukocytes in children receiving antileukemic therapy. Science 1963; 143: 1305–1311
   Google Scholar
• Graw R G, Jr, Buckner C D, Whang-Peng J, et al. Complication of bone marrow transplantation: graft-versus-host disease resulting from chronic myelogenous leukemia leukocyte transfusions. Lancet 1970; 2: 338–341
   PubMed Web of Science ®Google Scholar
• Brubaker D B. Human post-transfusion graft-versus-host disease. Vox Sang 1983; 45: 401–420
   PubMed Web of Science ®Google Scholar
• Schiffer C A, Aisner J, Dutcher J P, Wiernik P H. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983; 15: 65–74
   PubMed Web of Science ®Google Scholar
• Appelbaum F R, Norton L, Graw R G. Migration of transfused granulocytes in leukopenic dogs. Blood 1977; 49: 483–488
   PubMed Web of Science ®Google Scholar
• Eyre H J, Goldstein I M, Perry S, Graw R G, Jr. Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood 1970; 36: 432–442
   PubMed Web of Science ®Google Scholar
• Schwarzenberg L, Mathe G, Amiel J L, et al. Study of factors determining the usefulness and complications of leukocyte transfusions. Am J Med 1967; 43: 206–213
   PubMed Web of Science ®Google Scholar
• Appelbaum F R, Trapani R J, Graw R G, Jr. Consequence of prior alloimmunization during granulocyte transfusion. Transfusion 1977; 17: 460–464
   PubMed Web of Science ®Google Scholar
• Dahlke M B, Keashen M A, Alavi J B, et al. Response to granulocyte transfusion in the alloimmunized patient. Transfusion 1980; 20: 555–558
   PubMed Web of Science ®Google Scholar
• McCullough J, Weiblen B J, Clay M E, Forstron L. Effect of leukocyte antibodies on the fate in vivo of indium-111-labeled granulocytes. Blood 1981; 58: 164–170
   PubMed Web of Science ®Google Scholar
• Dahlke M B, Keashen M, Alavi J B, et al. Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsis. Transfusion 1982; 22: 374–378
   PubMed Web of Science ®Google Scholar
• Dutcher J P, Schiffer C A, Johnston G S, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983; 62: 354–360
   PubMed Web of Science ®Google Scholar
• Koza I, Holland J F, Cohen E. Histocompatible leukocyte transfusion during granulocytopenia. Neoplasma 1971; 18: 185–191
   PubMedGoogle Scholar
• Graw R G, Jr, Herzig G, Perry S, Henderson E S. Normal granulocyte transfusion therapy-treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972; 287: 367–371
   PubMed Web of Science ®Google Scholar
• Schiffer C A, Aisner J, Daly P A, et al. Alloimmunization following prophylactic granulocyte transfusion. Blood 1979; 54: 766–774
   PubMed Web of Science ®Google Scholar
• Ford J M, Cullen M H, Oliver R TD, Lister T A. Possible prolongation of remission in acute myeloid leukemia by granulocyte transfusions (letter). N Engl J Med 1980; 302: 583–584
   PubMed Web of Science ®Google Scholar
• Schiffer C A. Granulocyte transfusion therapy. Cancer Treat Rep 1983; 67: 113–119
   PubMedGoogle Scholar
• Dutcher J P. Granulocyte transfusion therapy. Am J Med Sci 1984; 287: 11–17
   PubMed Web of Science ®Google Scholar
• Saling E, Malchus R, Hoppe I. Prevention of fetal growth retardation by buffy-coat transfusions — a case report. J Perinat Med 1983; 11: 255–257
   PubMed Web of Science ®Google Scholar